Rafael Holdings NYSE: RFL
Rafael Holdings holds commercial real estate assets and interests in two clinical stage, oncology focused pharmaceutical companies.
Name | Rafael Holdings |
Ticker | RFL |
Exchange | NYSE |
Sector | Real Estate |
Industry | REITs Health Care & Senior Housing |
Price
52W Low/High |
35.78
10.40 / 45.35 |
Momentum | Strong Up |
Market cap | 566 M |
1Y Total Return |
90.72%
Strong |
1Y Volatility |
92.38%
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Rafael Holdings holds commercial real estate assets and interests in two clinical stage, oncology focused pharmaceutical companies.
Details
Ticker | RFL |
Name | Rafael Holdings |
ISIN | US75062E1064 |
CUSIP | 75062E106 |
Exchange | NYSE |
Sector | Real Estate |
Industry | REITs Health Care & Senior Housing |
Country | USA |
Currency | U.S. Dollar |
Share as of 2/26/21
Close Price | 35.78 |
52W Low/High | 10.40 / 45.35 |
Market cap | 566 M |
1Y Total Return |
90.72%
Strong |
1Y Volatility |
92.38%
High Risk |
Beta | 1.56 |
PE (trailing) | - |
12M Dividends | - |
Last Dividend Date | - |
Dividend Yield | - |
Fin. Strength
Net Profit Margin | -215.9% |
Cash from Op. / Cur. Liabilities | -1.21 |
Diluted Earnings / Share | -0.65 |
ROE | - |
ROIC | -8.2% |
Price / Revenue | 119.1 |
Price / Book | 4.9 |
Price / CF | -88.7 |
Current Ratio | 1.6 |
Cur.Liabilities / Tot.Liabilities | 1.0 |
Financial Leverage | 0.00 |
in Mils USD |
rolling-year up to September
|
||||
---|---|---|---|---|---|
Income Statement | 2020 | 2019 | 2018 | 2017 | |
Revenue |
5
|
5
|
4
|
5
|
|
Gross Profit |
5
|
5
|
4
|
5
|
|
R&D |
3
|
1
|
1
|
0
|
|
EBITDA |
-8
|
-4
|
-1
|
-
|
|
Operating Income |
-9
|
-7
|
-4
|
-1
|
|
Net Income exc. Extra |
-
|
-
|
-
|
-
|
|
per Share | |||||
Diluted avg Shares |
16
|
16
|
13
|
-
|
|
EPS exc. Extra |
-0.65
|
-0.41
|
-0.22
|
-
|
|
Dividend |
-
|
-
|
-
|
-
|
|
Div. Yield (an.) |
-
|
-
|
-
|
-
|
|
Balance Sheet | 2020 | 2019 | 2018 | 2017 | |
Total Assets |
135
|
140
|
117
|
-
|
|
Cash, Eq & Invt ShortTerm |
7
|
11
|
30
|
-
|
|
Total Current Assets |
8
|
12
|
34
|
-
|
|
Total Non-Current Assets |
126
|
129
|
82
|
-
|
|
Intangibles |
2
|
2
|
0
|
-
|
|
Total Liabilities |
5
|
1
|
2
|
-
|
|
Total Current Liabilities |
5
|
1
|
1
|
-
|
|
Long Term Debt |
0
|
0
|
1
|
-
|
|
Shareholder equity |
116
|
125
|
106
|
-
|
|
Cash Flow | 2020 | 2019 | 2018 | 2017 | |
Cash from Operations |
-6
|
-3
|
-3
|
-
|
|
Depreciation |
2
|
2
|
2
|
-
|
|
Cash from Investing |
3
|
-26
|
-1
|
-
|
|
Capex |
3
|
1
|
1
|
-
|
|
Cash from Financing |
0
|
31
|
2
|
-
|
|
Stock Issued |
0
|
8
|
1
|
-
|
|
Debt (LT) Issued |
0
|
18
|
0
|
-
|
|
Free Cash Flow |
-8
|
19
|
-
|
-
|
|
Ratios | 2020 | 2019 | 2018 | 2017 | |
Net Profit Margin |
-
|
-
|
-
|
-
|
|
NCFO / Op.Income |
-
|
-
|
-
|
-
|
|
Current Ratio |
1.6
|
9.7
|
46.1
|
-
|
|
Financial Leverage D/E |
0.00
|
0.00
|
0.00
|
-
|
|
Return on Capital Avg |
-8.2%
|
-5.2%
|
-5.4%
|
-
|
|
Return on Shareholder Equity |
-
|
-
|
-
|
-
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available